Argonaut Manufacturing Services opens custom controls & standards facility
The CMO has designed the new service to alleviate manufacturing challenges associated with positive controls and nucleic acid templates
Argonaut Manufacturing Services, a contract manufacturing organization for Life Science, Diagnostic, and BioPharma markets, has launched a new service offering to support the growing need for custom controls, standards and verification panels.
Formulating and filling these products will be performed at a new standalone facility in Carlsbad, California.
The company said the site has been designed to alleviate many of the concerns expressed with the manufacturing challenges associated with positive controls and nucleic acid templates.
Controls and standards are used regularly by innovators to verify instruments, reagents, and diagnostic tests to ensure standard operating procedures (SOPs) are followed properly for patient samples.
The Custom Molecular Controls and Standards service provides organizations focusing on diagnostics for the regulated markets and RUO (research use only) assays, a complete solution for their commercial products with Argonaut and controls that match the same quality standards that Argonaut Manufacturing Services provides.
“This service offering has been widely requested by our clients in every market from Point of Care device makers to platform companies,” said Wayne Woodard, CEO of Argonaut.
The CMO's new offering provides a wide range of solutions including synthetic PCR controls, antibodies, buffers, and markers. Controls and standards can also be lyophilized to both extend shelf-life and improve protocols.
Rather than being restricted to off-the-shelf controls or putting in the capital equipment and labour-intensive SOPs to manufacture their own controls, clients can quickly add controls that are specific for their assays.
Eric Blair, COO of Argonaut, said that with the company's strength in lyophilization, its Custom Molecular Controls and Standards service offers opportunities for improving assays by reducing waste due to shelf-life issues, and simplifying protocols by reducing pipetting and mixing steps.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance